CytoReason Expands Its Reach in Asia, Forging Commercial Alliance with Helixrus to Leverage Machine Learning in Drug Development for Korean Drugmakers

Farma Darya

TEL AVIV, Israel and SEOUL, South Korea, April 12, 2022 /PRNewswire/ — CytoReason, a leading developer of computational disease models for efficient drug discovery and development, announced today the signing of a commercial partnership with Helixrus, a leading Korean company focused on biological big data and multi-omics. The partnership will […]

Drug Discovery Outsourcing Market Report 2022-2032

Farma Darya

ReportLinker Forecasts by Service Type (Chemical Services, Biology Services, Lead Optimisation, Lead Identification & Screening, Others), by Molecule Type (Large Molecule Drugs, Small Molecule Drugs), by Therapeutic Area (Oncology, Infectious Disease, Central Nervous System, Immunology, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Others) AND Regional and Leading National Market Analysis PLUS […]

Tribun Health is Entering the Pharmaceutical and Drug Development Market to Meet the Challenges of Precision Medicine

Farma Darya

The Tribun Health executive team is growing with the creation of a VP Pharma position to develop the expanding pharmaceutical business. Drug development Drug development PARIS, April 26, 2022 (GLOBE NEWSWIRE) — Tribun Health (Formerly Tribvn Healthcare) is pleased to announce the company’s expansion into the pharmaceutical market with the […]